Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q50950
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q50950-F1 | Predicted | AlphaFoldDB |
No variants for Q50950
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q50950 | |||||
No associated diseases with Q50950
No regional properties for Q50950
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q50950 | |||
No GO annotations of cellular component
| Name | Definition |
|---|---|
| No GO annotations for cellular component |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| glycosyltransferase activity | Catalysis of the transfer of a glycosyl group from one compound (donor) to another (acceptor). |
1 GO annotations of biological process
| Name | Definition |
|---|---|
| lipopolysaccharide biosynthetic process | The chemical reactions and pathways resulting in the formation of lipopolysaccharides, any of a group of related, structurally complex components of the outer membrane of Gram-negative bacteria. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MQNHVISLAS | AAERRAHIAD | TFGSRGIPFQ | FFDALMPSER | LEQAMAELVP | GLSAHPYLSG |
| 70 | 80 | 90 | 100 | 110 | 120 |
| VEKACFMSHA | VLWEQALDEG | LPYIAVFEDD | VLLGEGAEQF | LAEDTWLEER | FDKDSAFIVR |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LETMFAKVIV | RPDKVLNYEN | RSFPLLESEH | CGTAGYIISR | EAMRFFLDRF | AVLPPERIKA |
| 190 | 200 | 210 | 220 | 230 | 240 |
| VDLMMFTYFF | DKEGMPVYQV | SPALCTQELH | YAKFLSQNSM | LGSDLEKDRE | QGRRHRRSLK |
| 250 | 260 | 270 | |||
| VMFDLKRALG | KFGREKKKRM | ERQRQAELEK | VYGRRVILFK |